Filing Details
- Accession Number:
- 0001209191-15-054363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-17 18:56:07
- Reporting Period:
- 2015-06-15
- Filing Date:
- 2015-06-17
- Accepted Time:
- 2015-06-17 18:56:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571819 | Lee Zane | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | Svp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-15 | 4,339 | $5.59 | 32,495 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-15 | 4,339 | $69.05 | 28,156 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-15 | 7,661 | $6.92 | 35,817 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-15 | 7,661 | $69.05 | 28,156 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-15 | 4,339 | $0.00 | 4,339 | $5.59 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-15 | 7,661 | $0.00 | 7,661 | $6.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,661 | 2022-03-13 | No | 4 | M | Direct | |
| 33,239 | 2021-03-31 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $68.51 to $69.50, inclusive.
- 1/4 of the shares subject to the option shall vest and become exercisable on the one-year anniversary of the Vesting Commencement Date, which is January 1, 2012, and 1/48 of the shares subject to the option shall vest and become exercisable each month thereafter.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
